Sentinel node biopsy and selective lymph node clearance—impact on regional control and survival in breast cancer and melanoma
- 5 May 2005
- journal article
- editorial
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 32 (6) , 631-634
- https://doi.org/10.1007/s00259-005-1801-4
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- The sentinel node procedure in patients with melanomaEuropean Journal of Surgical Oncology, 2004
- Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: A long term follow‐up analysisJournal of Surgical Oncology, 2004
- CommentaryJournal of Surgical Oncology, 2004
- The Risk of Axillary Relapse After Sentinel Lymph Node Biopsy for Breast Cancer Is Comparable With That of Axillary Lymph Node DissectionAnnals of Surgery, 2004
- Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanomaEuropean Journal of Surgical Oncology, 2004
- Clinical Outcome of Stage I/II Melanoma Patients After Selective Sentinel Lymph Node Dissection: Long-Term Follow-Up ResultsJournal of Clinical Oncology, 2003
- Current status of intraoperative lymphatic mapping and sentinel lymphadenectomy for melanoma: is it standard of care?11No competing interests declared.22The views expressed herein are those of the authors and do not necessarily reflect the views of the US Army, US Navy, Uniformed Services University of the Health Sciences, or the Department of Defense.Journal of the American College of Surgeons, 1999
- Introduction: Sentinel lymphadenectomy for patients with clinical stage I melanomaJournal of Surgical Oncology, 1997
- Melanoma: questions for the futureEuropean Journal of Surgical Oncology, 1996
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992